Pharmacokinetics of <scp>GS</scp>‐441524 following intravenous remdesivir in six cats and results of therapeutic drug monitoring during treatment of feline infectious peritonitis: 22 cases (2021–2024)
This study supports the use of RDV and GS-441524 for FIP treatment and suggests that population pharmacokinetic modelling is required to better explore the utility of therapeutic drug monitoring of GS-441524.
Authors
- Benjamin Kimble (ORCID: https://orcid.org/0000-0002-3778-4027)
- Merran Govendir (ORCID: https://orcid.org/0000-0003-3595-0500)
- Richard Malík (ORCID: https://orcid.org/0000-0002-6025-194X)
- Sally Coggins (ORCID: https://orcid.org/0000-0001-8683-5014)
- Edward J. Hall (ORCID: https://orcid.org/0000-0002-5306-082X)
- Jacqueline M. Norris (ORCID: https://orcid.org/0000-0002-0003-6930)
- Mary Thompson
Institutions
- The University of Sydney (AU)
Publication Details
- Journal
- Journal of Small Animal Practice
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1111/jsap.13849
- Citations
- 4
- Primary Topic
- Animal Virus Infections Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.77
Funders
- EveryCat Health Foundation